| |
| |
|
| Insider
Information: |
Bienaime Jean Jacques |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
539,056 |
|
|
Indirect Shares
|
247,533 |
|
|
| Direct
Value |
$43,131,096 |
|
|
|
Indirect Value
|
$21,938,850 |
|
|
| Total
Shares |
786,589 |
|
|
| Total
Value |
$65,069,946 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -34.0%
|
-5.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 34
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2022-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
40,280 |
378,849 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2022-04-29 |
4 |
A |
$62.41 |
$21,281 |
D/D |
341 |
335,324 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,144 |
12,988 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2022-11-02 |
4 |
A |
$86.12 |
$8,612 |
D/D |
100 |
322,924 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2023-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
167,532 |
487,856 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
36,100 |
523,956 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2023-04-28 |
4 |
A |
$66.88 |
$21,201 |
D/D |
317 |
426,213 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,505 |
15,493 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2023-10-04 |
4 |
A |
$85.57 |
$856 |
D/D |
10 |
422,742 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2023-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,370 |
425,112 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-01-08 |
4 |
A |
$99.05 |
$4,953 |
D/D |
50 |
425,162 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-01-18 |
4 |
A |
$92.60 |
$3,704 |
D/D |
40 |
419,602 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
143,601 |
563,203 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2005-09-01 |
4 |
AB |
$8.58 |
$38,588 |
D/D |
4,500 |
4,500 |
2.81 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2005-10-03 |
4 |
AB |
$8.51 |
$12,765 |
D/D |
1,500 |
6,000 |
2.81 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2005-10-06 |
4 |
AB |
$8.00 |
$4,000 |
D/D |
500 |
6,500 |
2.73 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2005-10-12 |
4 |
AB |
$7.00 |
$3,500 |
D/D |
500 |
6,500 |
2.73 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2005-10-12 |
4/A |
AB |
$7.00 |
$3,500 |
D/D |
500 |
7,000 |
2.73 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2005-11-01 |
4 |
AB |
$8.36 |
$12,550 |
D/D |
1,500 |
8,500 |
2.81 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
• • – |
2005-12-01 |
4 |
AB |
$9.89 |
$14,916 |
D/D |
1,500 |
10,000 |
2.81 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
• • – |
2006-02-01 |
4 |
AB |
$11.62 |
$17,500 |
D/D |
1,500 |
14,000 |
2.81 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2006-03-01 |
4 |
AB |
$12.96 |
$19,490 |
D/D |
1,500 |
15,500 |
2.81 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2006-04-03 |
4 |
AB |
$13.33 |
$20,019 |
D/D |
1,500 |
17,000 |
2.81 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2006-05-01 |
4 |
AB |
$12.55 |
$18,880 |
D/D |
1,500 |
18,500 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2006-06-01 |
4 |
AB |
$13.05 |
$19,575 |
D/D |
1,500 |
25,381 |
2.81 |
- |
|
850 Records found
|
|
Page 4 of 34 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
